Intersouth Partners

Intersouth Partners

Dennis Dougherty, a veteran operator who previously co-founded a successful software company, launched Intersouth Partners in 1985 as the venture capital ecosystem was taking shape in North Carolina's Research Triangle. The firm established itself early as a pivotal source of institutional capital for technology and life sciences companies in the Southeast, a region that was largely overlooked by coastal venture firms at the time. Its endurance through multiple market cycles — from the dot-com era through the post-pandemic venture reset — marks it as a structural fixture in Southeastern early-stage finance. Intersouth deploys capital across early-stage and growth-equity rounds, targeting enterprise software, digital health, AI/ML, and agtech companies. The firm typically leads or co-leads Series A and B rounds, often acting as the first institutional check for founders spinning out of the region's research universities. Its portfolio has included companies such as Icagen, a Duke University spinout that went public and was later acquired by Pfizer (per Triangle Business Journal, 2011), and Cree, the Durham-based LED and semiconductor company that became one of the region's landmark technology IPOs. The firm invests primarily in the Southeastern US, with a concentration in North Carolina, Georgia, and Virginia. Intersouth has raised multiple fund vintages across its four-decade history, operating as a classic venture partnership with a generalist thesis within its chosen sectors. The firm's team size and assets under management are not publicly disclosed. Its posture has consistently emphasized company-building alongside academic and research institutions, leveraging proximity to Duke, UNC, and NC State. In recent years, the firm has maintained a lower public profile while its portfolio companies have continued to attract co-investment from larger national venture firms in later rounds. Intersouth's structural differentiator is its deep, four-decade embed in the Research Triangle's innovation fabric — a network effect built through generations of founders, university tech-transfer offices, and regional limited partners that most coastal funds cannot replicate. That regional concentration functions as both a moat and a constraint: it gives the firm privileged access to deal flow within its geography, but also ties its returns to the pace of startup creation in the Southeast rather than the broader national market.